NATCOPHARM logo

Natco Pharma LTD.

NATCOPHARM·NSE·
847.75 +6.25 (+0.74%)
Market Cap15215.58 Cr
PE Ratio10.70
Volume2,30,334
Day High - Low853.75 - 837.40
52W High-Low1226.80 - 789.00
DocStoX Score
6.9/10
Fair
Fair Value
Sign in to see
ROE
16.90%
Strong
P/E
10.70x
Cheap
Debt / Equity
0.08
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

NIFTY 500NIFTY SMALLCAP 250
Day837.40
853.75
52W789.00
1227
DocStoX take

Supported by growth (8.8) and risk (8.5), but held back by momentum (0.0). Growth looks strong at 8.8, but that is offset by momentum at 0.0. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
6.9
/10
Fair
Quality
Solid
ROE 16.9%
Valuation
Cheap
P/E 10.7×
Growth
Strong
Revenue +14.7% 5Y CAGR
Risk
Low risk
D/E 0.08
Momentum
Weak
13% of 52-week range

At a glance

Market Cap
₹15,216 Cr
52W High / Low
₹1227 / ₹789
Dividend Yield
0.17%
Promoter Holding
49.42%
EPS (TTM)
₹79.20
Book Value
₹515.00

Key highlights

  • Healthy net margin (35%)
  • Low leverage — D/E 0.08
  • Profitable in all of the last 5 years
  • Momentum is weak (0.0/10)
  • Near the bottom of its 52-week range (13%)
4 Positives2 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

NATCO PHARMA LTD. peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.